Efficacy and safety of Nintedanib for idiopathic pulmonary fibrosis: a meta-analysis

Yi-ran WANG; Qiao YE.
Chinese Journal of Practical Internal Medicine ; (12): 698-704, 2019.
Artículo en Zh | WPRIM | ID: wpr-816092

Documentos relacionados

  1. [Idiopatic pulmonary fibrosis: A new paradigm].
  2. [Idiopathic pulmonary fibrosis: The current state of the problem].
  3. [The Role of Bronchoalveolar Lavage in the Diagnosis of Idiopathic Pulmonary Fibrosis: An Investigation of the Relevance of the Protein Content].
  4. [Idiopathic pulmonary fibrosis: new insights].
  5. [Myocardial fibrosis: Current aspects of the problem].